ALLO
#2728
Allogene Therapeutics, Inc. - Common Stock
1.9 3 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.50%
Monthly Change
0.00%
6 month change
+12.21%
Year Change
+49.61%
Previous Close
2.0 0
Open
1.9 3
Low
1.9 3
High
1.9 3
Volume
107
Financials
- Market Capitalization 666.15 M
- Employee 152
- Founded 2017
- CEO N/A
- Website www.allogene.com
- Headquarter California, United States
- FIGI BBG00KHRRDX3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.57
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2718 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 6.45 USD | +0.62% | +1.74% | -3.30% | +957.38% | 676.54 M USD | ||
| 2722 |  PTCT PTC Therapeutics, Inc. - Common Stock | 81.33 USD | -4.15% | -6.33% | +12.91% | +64.50% | 674.63 M USD | ||
| 2740 |  RGNX REGENXBIO Inc. - Common Stock | 12.75 USD | -8.60% | -14.03% | +87.78% | -5.06% | 659.14 M USD | ||
| 2746 |  CRMD CorMedix Inc. - Common Stock | 8.32 USD | -0.95% | -4.70% | -6.62% | -26.37% | 652.72 M USD |
Frequently asked questions about Allogene Therapeutics, Inc. - Common Stock
What is the Allogene Therapeutics, Inc. - Common Stock stock price today?
The current price of Allogene Therapeutics, Inc. - Common Stock (ALLO) is 1.9300000000000002. Over the past 24 hours, the stock has changed by -3.50%. Follow the ALLO chart for real-time price dynamics.
What is the stock ticker of Allogene Therapeutics, Inc. - Common Stock?
Allogene Therapeutics, Inc. - Common Stock trades under the ticker ALLO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Allogene Therapeutics, Inc. - Common Stock stock going up?
ALLO has changed by -8.10% over the last week, 0.00% over the last month, and +49.61% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Allogene Therapeutics, Inc. - Common Stock net income for the last quarter?
Allogene Therapeutics, Inc. - Common Stock reported net income of -42.61 M for the last quarter. The previous quarter showed -38.81 M, which means net income changed by -9.78%.
How many employees does Allogene Therapeutics, Inc. - Common Stock have?
As of the latest available data, Allogene Therapeutics, Inc. - Common Stock has 152 employees. Workforce size can provide additional context about the company's scale and operations.
What is Allogene Therapeutics, Inc. - Common Stock EBITDA?
Allogene Therapeutics, Inc. - Common Stock EBITDA is -42.42 M, and its EBITDA margin is -5 302.88%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Allogene Therapeutics, Inc. - Common Stock stock?
You can buy Allogene Therapeutics, Inc. - Common Stock (ALLO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Allogene Therapeutics, Inc. - Common Stock stock?
Investing in Allogene Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALLO chart and related analysis on metatrader.com as part of your research.